Truvestments Capital’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93 | Buy |
+4
| New | +$93 | ﹤0.01% | 932 |
|
|
2025
Q1 | – | Sell |
-8
| Closed | -$141 | – | 1175 |
|
|
2024
Q4 | $141 | Buy |
8
+3
| +60% | +$53 | ﹤0.01% | 981 |
|
|
2024
Q3 | $54 | Buy |
+5
| New | +$54 | ﹤0.01% | 920 |
|
|
2024
Q2 | – | Sell |
-5
| Closed | -$160 | – | 718 |
|
|
2024
Q1 | $160 | Hold |
5
| – | – | ﹤0.01% | 707 |
|
|
2023
Q4 | $131 | Hold |
5
| – | – | ﹤0.01% | 776 |
|
|
2023
Q3 | $296 | Hold |
5
| – | – | ﹤0.01% | 659 |
|
|
2023
Q2 | $498 | Hold |
5
| – | – | ﹤0.01% | 656 |
|
|
2023
Q1 | $864 | Sell |
5
-2
| -29% | -$346 | ﹤0.01% | 613 |
|
|
2022
Q4 | $2.57K | Hold |
7
| – | – | ﹤0.01% | 678 |
|
|
2022
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 578 |
|
|
2022
Q2 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 584 |
|
|
2022
Q1 | – | Sell |
-7
| Closed | -$3K | – | 577 |
|
|
2021
Q4 | $3K | Hold |
7
| – | – | ﹤0.01% | 539 |
|
|
2021
Q3 | $4K | Hold |
7
| – | – | ﹤0.01% | 490 |
|
|
2021
Q2 | $3K | Hold |
7
| – | – | ﹤0.01% | 528 |
|
|
2021
Q1 | $5K | Buy |
7
+1
| +17% | +$714 | ﹤0.01% | 527 |
|
|
2020
Q4 | $3K | Buy |
+6
| New | +$3K | ﹤0.01% | 537 |
|
|
2020
Q3 | – | Sell |
-6
| Closed | -$3K | – | 576 |
|
|
2020
Q2 | $3K | Buy |
+6
| New | +$3K | ﹤0.01% | 497 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 557 |
|
|
2019
Q4 | – | Sell |
-10
| Closed | -$7K | – | 629 |
|
|
2019
Q3 | $7K | Sell |
10
-1
| -9% | -$700 | ﹤0.01% | 542 |
|
|
2019
Q2 | $9K | Hold |
11
| – | – | 0.01% | 545 |
|
|
2019
Q1 | $8K | Buy |
+11
| New | +$8K | 0.01% | 549 |
|
|
2018
Q3 | $10K | Buy |
+12
| New | +$10K | ﹤0.01% | 644 |
|